Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 140501 - 140520 out of 485363 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+13X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+2X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+3X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+4X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+5X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+6X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+7X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+8X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 1X5,5ML+9X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 10X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 11X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 12X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 13X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 14X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 2X5,5ML+1X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 2X5,5ML+10X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 2X5,5ML+11X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 2X5,5ML+12X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 2X5,5ML+2X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
| Czech Republic | (M09AX09) onasemnogene abeparvovec | ZOLGENSMA | 2X10^13VG/ML, 2X10^13VG/ML INF SOL 2X5,5ML+3X8,3ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited,Dublin |
Pages
